(2) A licensee shall maintain proof of consent for telehealth treatment in the patient’s up-
to-date medical record and satisfy section 16213 of the code, MCL 333.16213.
(3) A licensee providing a telehealth service may prescribe a drug if the licensee is a
prescriber acting within the scope of the licensee’s practice and in compliance with section
16285 of the code, MCL 333.16285, and if the licensee does both of the following:
(a) Refers the patient to a provider who is geographically accessible to the patient, if
medically necessary.
(b) Makes the licensee available to provide follow-up care services to the patient, or to
refer the patient to another provider, for follow-up care.
(4) A licensee providing any telehealth service shall do both of the following:
(a) Act within the scope of the licensee’s practice.
(b) Exercise the same standard of care applicable to a traditional, in-person healthcare
service.
History: 2021 AACS; 2023 AACS; 2024 AACS.
R 338.2409 Prescribing of drugs by physician’s assistants; procedures and protocols.
Rule 109. (1) Under sections 17048(2) and 17076(2) of the code, MCL 333.17048 and
333.17076, and under the terms of a practice agreement, a physician’s assistant may
prescribe a drug, including a controlled substance that is included in schedules 2 to 5 of
part 72 of the code, MCL 333.7201 to 333.7231, subject to both of the following
requirements:
(a) If a physician's assistant prescribes a drug, the physician's assistant's name must be
used, recorded, or otherwise indicated in connection with that prescription.
(b) If a physician's assistant prescribes a drug that is included in schedules 2 to 5, the
physician's assistant's Drug Enforcement Agency (DEA) registration number must be used,
recorded, or otherwise indicated in connection with that prescription.
(2) Under sections 17048(2) and 17076(3) of the code, MCL 333.17048 and 333.17076,
and under the terms of a practice agreement, a physician's assistant may order, receive, and
dispense complimentary starter dose drugs, including controlled substances that are
included in schedules 2 to 5 of part 72 of the code, MCL 333.7201 to 333.7231, subject to
both of the following requirements:
(a) If a physician's assistant orders, receives, or dispenses a complimentary starter dose
drug, the physician's assistant's name must be used, recorded, or otherwise indicated in
connection with that order, receipt, or dispensing.
(b) If a physician's assistant orders, receives, or dispenses a complimentary starter dose
drug that is included in schedules 2 to 5, the physician's assistant's DEA registration
number must be used, recorded, or otherwise indicated in connection with that order,
receipt, or dispensing.
History: 2016 AACS; 2021 AACS.
R 338.2411 Delegation of prescribing controlled substances to an advanced practice
registered nurse; limitation.
Page 2